Quantifying the effect of changes in the hemodialysis prescription on effective solute removal with a mathematical model

One potential benefit of chronic hemodialysis (HD) regimens of longer durat ion or greater frequency than typical three-times-weekly schedules is enhan ced solute removal over a relatively wide molecular weight spectrum of urem ic toxins. This study assesses the effect of variations in HD frequency (F: per week), duration (T: min per treatment), and blood/dialysate flow rates (Q(B)/Q(D) ml/min) on steady-state concentration profiles of five surrogat es: urea (U), creatinine (Cr), vancomycin (V), inulin (I), and beta(2)-micr oglobulin (beta 2M). The regimens assessed for an anephric 70-kg patient we re: A (standard): F = 3, T= 240, Q(B) = 350, Q(D) = 600; B (daily/short-tim e): F = 7, T = 100, Q(B) = 350, Q(D) = 600; C/D/E (low-flow/long-time): F = 3/5/7, T = 480, Q(B) = 300, Q(D) = 100. HD was simulated with a variable-v olume double-pool model, which was solved by numerical integration (Runge-K utta method). Endogenous generation rates (G) for U, Cr, and beta 2M were 6 .25, 1.0, and 0.17 mg/min, respectively; constant infusion rates for V and I of 0.2 and 0.3 mg/min, respectively, were used to simulate middle molecul e (Mh?)G values. Intercompartment clearances of 600, 275, 125, 90, and 40 m l/min were used for U, Cr, V, I, and beta 2M, respectively, For each solute /regimen combination, the equivalent renal clearance (EKR: ml/min) was calc ulated as a dimensionless value normalized to the regimen A EKR, which was 13.4, 10.8, 6.6, 3.7, and 4.8 ml/min for U, Cr, V, I, and beta 2M, respecti vely. For regimens B, C, D, and E, respectively, these normalized EKR value s were U: 1.04, 0.96, 1.58, and 2.22; Cr: 1.03, 1.08, 1.80, and 2.55; V: 1. 06, 1.32, 2.21, and 3.12; I: 1.05, 1.54, 2.57, and 3.62; beta 2M: 1.00, 1.2 7, 1.73, and 2.19. The extent of post-HD rebound (%) was highest for regime ns A and B, ranging from 16% (urea) to 50% (inulin), and lowest for regimen E, ranging from 6% (urea) to 28% (beta 2M). The following conclusions can be made: (I) Relative to a standard three-rimes-weekly IID regimen of appro ximately the same total (weekly) treatment duration, a daily/short-time reg imen results in modest (3 to 6%) increases in effective small solute and MM removal. (2) Relative to a standard three-times-weekly HD regimen, a three -times-weekly low-flow/long-time regimen results in comparable effective sm all solute removal and progressive increases in MM and beta 2M removal. A d aily low-flow/long-time regimen substantially increases the effective remov al of all solutes.